Off-pump coronary artery bypass graft operation in a patient with systemic sclerosis and sjogren’s syndrome

Yıl 2019, Cilt: 5 Sayı: 1, 1436 - 1439, 15.04.2019

Arda Aybars Pala Temmuz Taner Ahmet Burak Tatlı

https://doi.org/10.30569/adiyamansaglik.493105

Öz

Systemic sclerosis and
sjogren’s syndrome are autoimmune connective tissue diseases that can occur
with vascular involvement. Clinically cardiovascular involvement is uncommon, however
it is a bad prognostic factor if it is symptomatic. We aimed to present our
off-pump coronary artery bypass graft operation experience with a 49 year old
female diabetic patient who has systemic sclerosis and sjogren’s syndrome.

Anahtar Kelimeler

Off-pump coronary artery bypass graft, systemic sclerosis, sjogren’s syndrome

Sistemik sklerozis ve sjögren sendromu olan hastada off-pump koroner arter baypas greft cerrahisi

Öz

Sistemik sklerozis ve sjögren
sendromu vasküler tutulum yapabilen birer otoimmün bağ dokusu hastalıklarıdır.
Klinik
olarak kardiyovasküler tutulum nadirdir, ancak semptomatik ise kötü bir
prognostik faktördür.  Biz bu yazıda
sistemik
sklerozisi ve sjögren sendromu olan 49 yaşında diabetik bir kadın hastada
off-pump koroner arter baypas greft cerrahisi tecrübemizi aktarmayı amaçladık. 

Anahtar Kelimeler

off-pump koroner arter baypas greft, sistemik sklerozis, sjögren sendromu

Kaynakça

• 1. Kahan A, Allanore Y. Primary myocardial involvement in systemic sclerosis. Rheumatology (Oxford). 2006 Oct;45 Suppl 4:iv14-7. Review.
• 2. Nikolov PN, Gabor GI. Pathogenesis of Sjogren’s syndrome. Curr Opin Rheum 2009; 21:465-470.
• 3. Birdas TJ, Landis JT, Haybron D, Evers D, Papasavas PK, Caushaj PF. Outcomes of coronary artery bypass grafting in patients with connective tissue diseases. Ann Thorac Surg. 2005 May;79(5):1610-4.
• 4. Nussinovitch U, Shoenfeld Y. Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality. Autoimmun Rev. 2011 Mar;10(5):259-66. doi: 10.1016/j.autrev.2010.09.014. Epub 2010 Sep 21.
• 5. Kahaleh MB. Raynaud phenomenon and the vascular disease in scleroderma. Curr Opin Rheumatol. 2004 Nov;16(6):718-22.
• 6. Ungprasert P, Charoenpong P, Ratanasrimetha P, Thongprayoon C, Cheungpasitporn W, Suksaranjit P. Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis. Clin Rheumatol. 2014 Aug;33(8):1099-104.
• 7. Rahman A, Burma O, Bayar MK, Beştaş A, Uysal A, Üstündağ B. Kardiyopulmoner bypass ve çalışan kalp teknikleri ile yapılan ameliyatların kardiyak performansa etkisi. Turkish J Thorac Cardiovasc Surg. 2001;9:68-73.
• 8. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS guidelines on myocardial revascularization. Kardiologia Polska (Polish Heart Journal). 2014;72(12):1253-1379.
• 9. Ilonze OJ, Ritter N. The optimal management of patients with systemic scleroderma and coronary artery disease. Journal of the National Medical Association, Volume 104, Issue 3, Pages 215-218.